
    
      This is a retrospective cohort study using anonymized information from patients with ENKTL.
      The following criteria are required: (1) Patients diagnosed with ENKTL, nasal type between
      January 1, 1995 and December 31, 2014; (2) Patients treated with non-anthracycline based
      therapy as an initial treatment. The pathology of initial diagnosis was reviewed by
      designated pathologists.
    
  